4.7 Review

Structural insights on druggable hotspots in CD147: A bull's eye view

Journal

LIFE SCIENCES
Volume 224, Issue -, Pages 76-87

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2019.03.044

Keywords

CD147; Hotspots; Drug design; EMMPRIN

Funding

  1. Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR21490/MED/30/1773/2016]

Ask authors/readers for more resources

CD147/Basigin/EMMPRIN (Extracellular Matrix Metalloproteinase inducer) is a single pass typel transmembrane protein playing a central role in developmental process, wound healing, nutrient transport, inflammation, arthritis and also in microbial pathologies. It is also found to be a potent stimulator of MMP (matrix metalloproteinases) and has been considered as a prognostic marker in cancer. Dysregulation of CD147 is reported in several types of cancer. It activates cell proliferation, invasion, metastasis and inhibits tumor cell apoptosis under hypoxic condition. Thus, CD147 serves as a hub protein in cancer, as it is involved in several homophilic and heterophilic cellular interactions spanning the major hallmarks of cancer. Targeting these interactions is considered to be an efficient therapeutic modality in cancerous conditions. Hence, by this review we intend to collate the structure-function relationships of CD147, with an exclusive thrust on potential druggable hotspots based on its intra and inter molecular interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available